Federal Register / Vol. 86, No. 142 / Wednesday, July 28, 2021 / Notices 40601 

check, bank draft, or money order. Mail 

the payment and a copy of the 

completed Animal Drug User Fee Cover 

Sheet to: Food and Drug 

Administration, P.O. Box 979033, St. 

Louis, MO 63197–9000. Note: in no case 

should the payment for the fee be 

submitted to FDA with the application. 

When paying by wire transfer, the 

invoice number or PIN needs to be 

included; without the invoice number 

or PIN, the payment may not be applied 

and the invoice amount would be 

referred to collections. The originating 

financial institution may charge a wire 

transfer fee. If the financial institution 

charges a wire transfer fee, it is required 

to add that amount to the payment to 

ensure that the invoice is paid in full. 

Use the following account 

information when sending a payment by 

wire transfer: U.S. Department of the 

Treasury, TREAS NYC, 33 Liberty St., 

New York, NY 10045, FDA Deposit 

Account Number: 75060099, U.S. 

Department of the Treasury routing/ 

transit number: 021030004, SWIFT 

Number: FRNYUS33. 

To send a check by a courier such as 

Federal Express, the courier must 

deliver the check and printed copy of 

the cover sheet to: U.S. Bank, Attn: 

Government Lockbox 979033, 1005 

Convention Plaza, St. Louis, MO 63101. 

(Note: This address is for courier 

delivery only. If you have any questions 

concerning courier delivery, contact 

U.S. Bank at 314–418–4013. This 

telephone number is only for questions 

about courier delivery.) 

It is important that the fee arrives at 

the bank at least a day or two before the 

application arrives at CVM. FDA records 

the official application receipt date as 

the later of the following: The date the 

application was received by CVM, or the 

date U.S. Bank notifies FDA that your 

payment in the full amount has been 

received, or when the U.S. Treasury 

notifies FDA of receipt of an electronic 

or wire transfer payment. U.S. Bank and 

the U.S. Treasury are required to notify 

FDA within 1 working day, using the 

PIN described previously. 

The tax identification number of FDA 

is 53–0196965. 

B. Application Cover Sheet Procedures 

Step One—Create a user account and 

password. Log on to the ADUFA website 

at https://www.fda.gov/industry/animaldrug-user-fee-act-adufa/animal-druguser-fee-cover-sheet and, under 

Application Submission Information, 

click on ‘‘Create ADUFA User Fee Cover 

Sheet.’’ For security reasons, each firm 

submitting an application will be 

assigned an organization identification 

number, and each user will also be 

required to set up a user account and 

password the first time you use this site. 

Online instructions will walk you 

through this process. 

Step Two—Create an Animal Drug 

User Fee Cover Sheet, transmit it to 

FDA, and print a copy. After logging 

into your account with your user name 

and password, complete the steps 

required to create an Animal Drug User 

Fee Cover Sheet. One cover sheet is 

needed for each animal drug application 

or supplement. Once you are satisfied 

that the data on the cover sheet are 

accurate and you have finalized the 

cover sheet, you will be able to transmit 

it electronically to FDA and you will be 

able to print a copy of your cover sheet 

showing your unique PIN. 

Step Three—Send the payment for 

your application as described in section 

IX.A. 

Step Four—Please submit your 

application and a copy of the completed 

Animal Drug User Fee Cover Sheet to 

the following address: Food and Drug 

Administration, Center for Veterinary 

Medicine, Document Control Unit 

(HFV–199), 7500 Standish Pl., 

Rockville, MD 20855. 

C. Product, Establishment, and Sponsor 

Fees 

By December 31, 2021, FDA will issue 

invoices and payment instructions for 

product, establishment, and sponsor 

fees for FY 2022 using this fee schedule. 

Payment will be due by January 31, 

2022. FDA will issue invoices in 

November 2022 for any products, 

establishments, and sponsors subject to 

fees for FY 2022 that qualify for fees 

after the December 2021 billing. 

Dated: July 20, 2021. 

Lauren K. Roth, 

Acting Principal Associate Commissioner for 

Policy. 

[FR Doc. 2021–16043 Filed 7–27–21; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Biomedical Sensing, Measurement 

and Instrumentation. 

Date: August 12, 2021. 

Time: 1:00 p.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Yordan V. Kostov, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20817, 301–867–5309, kostovyv@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: July 22, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–15990 Filed 7–27–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

Council on Alcohol Abuse and 

Alcoholism. The meeting will be open 

to the public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The open 

session will be videocast and can be 

accessed from the NIH Videocasting and 

Podcasting website (http://

videocast.nih.gov/). 

A portion of the meeting will be 

closed to the public in accordance with 

the provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 


khammond on DSKJM1Z7X2PROD with NOTICES